Photo from wikipedia
I read the cost of illness article by Bebo et al.1 with great interest, which analyzed costs related to multiple sclerosis (MS) in the United States. The main driver of… Click to show full abstract
I read the cost of illness article by Bebo et al.1 with great interest, which analyzed costs related to multiple sclerosis (MS) in the United States. The main driver of direct costs was disease-modifying therapies (DMTs), while the biggest indirect cost factors were productivity loss for persons with MS and their caregivers. The authors did not include Medicaid or veteran populations in their cost estimates, and likely their reported findings are underestimates.
Keywords:
sclerosis united;
response economic;
reader response;
multiple sclerosis;
united states
Journal Title: Neurology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Neurology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!